CACNA1B and neoplasm: Next, we correlated CACNA1B (Cav2.2) protein expression with NSCLC patients' clinical characteristics, including gender, age at diagnosis, tumor size, histopathology grading, lymph node metastasis, smoking history, and TNM stage.